To Treat or Not to Treat a Fever? Rethinking Best Practices for Flu …

MedCram

R. Seheult

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Recent Increase in Norovirus Outbreaks, Human Cases of H5N1 Avian In…

MicrobeTV

D. Griffin, V. Racaniello

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Long COVID Update: What We Know Now

California Medical Association

N. Viswanathan

Clinical Pearls: Assessment & Management of ME/CFS and Long COVID

Bateman Horne Center

J. Bell

State of the state: Cardiovascular Dysautonomias - Long COVID-Explor…

Brian Olshansky

Long COVID: A Deep Dive into Prevalence, Symptoms, and Treatment Nee…

Long Covid the Answers

D. Altman, F. Okunola

Demystifying Medicine - Emerging Infectious Diseases and Other Publi…

National Institutes of Health (NIH)

A. Fauci, A. Gawande

Year in Review: Long COVID and ME/CFS in 2024

Infectious Diseases Year in Review

C. Shepherd

ASH 2024 Summary: Full or Reduced Dose Apixaban or Rivaroxaban for E…

2024 ASH Annual Meeting Insights Hub

J. Schaefer

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Lithium Aspartate Therapy for Neuro Long COVID

University at Buffalo Neurology Department

T. Guttuso Jr.

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

Post COVID Syndrome: Where Are We Now?

University of Colorado Department of Medicine

K. Erlandson

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

AHA 2024 Insights: Rivaroxaban for 18 Months versus 6 Months in Canc…

AHA 2024 Insights

Y. Yamashita

The "Postponement" of the Advisory Committee on Immunization Practic…

MicrobeTV

D. Griffin, V. Racaniello